Germany’s Linde agreed to revive talks with US rival Praxair to create a $65 billion industrial gases giant which will have its main operations run from Connecticut, two sources familiar with the deal said on Wednesday.
The deal is being pursued as a “merger of equals” thanks to a 50:50 valuation split, these people said.
But a combined company will have its operating base in Danbury, Connecticut, where Praxair is headquartered and Praxair’s Chief Executive Steve Angel will head the merged company, these sources said on Wednesday, after Linde confirmed it would resume talks.
In a largely symbolic gesture, Linde will be the name of the combined company, and Wolfgang Reitzle, Linde’s chairman would also be chairman of the combined firm, the sources said.
A “meaningful” representation would be retained in Germany, these people said, adding that the primary listing would be in New York and the secondary listing in Frankfurt.
Talks broke down in September amid disagreements over where the combined firm would have its headquarters and research and development, as well as over who would occupy the main management roles, sources told Reuters at the time.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
European Commission Approves Nippon Steel’s $14.9 Billion Buyout of U.S. Steel
May 6, 2024 by
CPI
Banco Sabadell Rejects Rival BBVA Merger Proposal
May 6, 2024 by
CPI
Novo Nordisk Foundation’s Acquisition Faces Regulatory Hurdles
May 6, 2024 by
CPI
Microsoft’s MAI-1 to Compete with Google and OpenAI in AI Language Models
May 6, 2024 by
CPI
Qantas Settles ‘Ghost Flights’ Case With Australian Watchdog for $120 Million
May 6, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI